Drug Trial Radar · NCT00512317
Open-label Extension to Protocol 1042-0600
Last checked: Nov 19, 2026Latest source record: Jan 17, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
123
Actual
Start
Jun 2007
Primary completion
Dec 2009
Study completion Sep 2013
Sponsor
- Lead sponsor
- Marinus PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Aug 7, 2007
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 69 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To allow open-label extension to patients who have completed Protocol 1042-0600.
Conditions
- Epilepsies, Partial
Interventions
ganaxoloneDrug
liquid suspension dosed tid
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline in Weekly Seizure Frequency During Weeks 1 Through 117Time frame: Baseline (Day 0) and Week 1 through Week 117
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama
Birmingham, Alabama
Barrow Neurological Institute
Phoenix, Arizona
Arkansas Epilepsy Program
Little Rock, Arkansas
University of Southern California Adult Comprehensive Epilepsy Center
Los Angeles, California
University of California-Davis
Sacramento, California
Anchutz Outpatient Pavillion Neurosciences Clinic/ University of Colorado Hospital
Aurora, Colorado
Yale University School of Medicine
New Haven, Connecticut
University of Florida McKnight Brain Institute
Gainesville, Florida
Intercoastal Neurology
Sarasota, Florida
Emory HealthCare
Atlanta, Georgia
Southern Illinois University Medical Center
Springfield, Illinois
University of Iowa Hospitals and Clinics
Iowa City, Iowa
University of Kentucky, Dept. of Neurology
Lexington, Kentucky
Mid-Atlantic Epilepsy and Sleep Center
Bethesda, Maryland
2799 West Grand blvd. CFP 071
Detroit, Michigan
Minnesota Epilepsy Group, PA
Saint Paul, Minnesota
Comprehensive Epilepsy Care Center for Children and Adults
Chesterfield, Missouri
Neurosciences Institute at Albany Medical Center
Albany, New York
SUNY Upstate Medical University
Syracuse, New York
Ohio State University Medical Center
Columbus, Ohio
Riddle Health Care Center for Neuroscience
Media, Pennsylvania
Thomas Jefferson University
Philadelphia, Pennsylvania
Vanderbilt University Medical Center
Nashville, Tennessee
Neurological Clinic of Texas, P.A.
Dallas, Texas
Virginia Commonwealth University
Richmond, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.